AUG 14, 2026 · JOURNAL ARTICLE
Development of a multi-modal PeRsOnalised PrEhabilitation intervention for people with acute myeloid Leukaemia: the PROPEL trial
Nihr Open Research
This is a development and feasibility study describing the creation of a prehabilitation intervention, not yet reporting efficacy or safety outcomes; the phase III trial is ongoing and will provide the evidence needed to judge clinical impact.
Reported
Annual AML incidence in UKapproximately 3,100 people
Trial registration date26/05/2023
Trial opening dateSeptember 2023